chr17-61400352-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_005994.4(TBX2):c.176G>A(p.Gly59Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000081 in 1,012,440 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005994.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBX2 | NM_005994.4 | c.176G>A | p.Gly59Glu | missense_variant | Exon 1 of 7 | ENST00000240328.4 | NP_005985.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000102 AC: 15AN: 146720Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000786 AC: 68AN: 865612Hom.: 0 Cov.: 30 AF XY: 0.0000966 AC XY: 39AN XY: 403772
GnomAD4 genome AF: 0.0000953 AC: 14AN: 146828Hom.: 0 Cov.: 32 AF XY: 0.000154 AC XY: 11AN XY: 71470
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.176G>A (p.G59E) alteration is located in exon 1 (coding exon 1) of the TBX2 gene. This alteration results from a G to A substitution at nucleotide position 176, causing the glycine (G) at amino acid position 59 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at